New Treatment for Retinal Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 371
Special Issue Editors
Interests: oxidative stress; molecular basis; retinal development and degeneration
Special Issue Information
Dear Colleagues,
Blinding retinal diseases are a major, and rapidly growing, public health problem around the world. Although great strides have been made in our understanding of these diseases, we still lack effective treatments for many of them. While we have treatments that block the end stage of Macular Degeneration, these do not stop the progressive retinal degeneration that leads to blindness. Similarly, we have interventions that blunt the effects of end stage neovascularization in diabetic retinopathy, but no treatments that can prevent the early stages of the disease. Increased intraocular pressure leading to glaucoma can be treated surgically or with drugs, but many glaucoma patients have little or no increase in intraocular pressure, and there are currently no options for these patients. Other blinding conditions, though less prevalent, are also in need of new treatments.
Fortunately, there are hopeful signs of new therapies for these and related diseases. The goal of this special issue is to highlight new and emerging therapies that have the potential to revolutionize treatment of degenerative retina disease. From gene therapy to epigenetic modifiers to small molecule anti-oxidants to innovative drug delivery methods, all of these offer hope to millions of patients. With both review articles and original research papers we will explore the potential and the pitfalls of new treatments currently under development.
Prof. Dr. Colin J. Barnstable
Prof. Dr. Joyce Tombran-Tink
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene therapy
- exosomes
- drug delivery
- nanoparticles
- epigentic modifiers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
